Clinical Trial Update: Effects of Erythropoietin for Cognitive Side-effects of ECT [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating erythropoietin for cognitive side-effects associated with electroconvulsive therapy; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Major Depressive Disorder

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Martin Balslev Jørgensen | Conditions: ECT, Cognitive Impairment | Phase 2 | Status: COMPLETED